Insider Trading activities of Endo International Plc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Endo International Plc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Endo International Plc since year 2005. Table 2 shows the detailed insider transactions of Endo International Plc since 2005. The reporting company's ticker symbol is ENDP. The reporting company's CIK number is 1593034.
The total value of stock buying since 2005 is $3,399,027.
The total value of stock sales since 2005 is $38,892,294.
The total value of stock option exercises since 2005 is $14,427,776.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Endo International Plc (ENDP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 36,000 $279,460 0 $0 0 $0
2017-03 2,300 $24,656 5,325 $57,616 0 $0
2016-11 0 $0 14,000 $249,060 0 $0
2016-05 36,000 $549,500 0 $0 0 $0
2016-03 5,875 $233,987 13,652 $575,976 163,559 $281,855
2015-11 22,597 $1,266,221 8,000 $443,840 30,384 $1,027,851
2015-06 2,500 $202,750 0 $0 0 $0
2015-04 0 $0 105,562 $9,701,147 105,562 $3,137,237
2015-03 0 $0 88,271 $7,703,599 82,471 $2,112,929
2014-11 3,700 $247,678 0 $0 0 $0
2014-10 0 $0 0 $0 4,567 $136,279
2014-08 3,500 $229,775 0 $0 20,000 $441,200
2014-06 0 $0 6,764 $465,566 6,764 $166,597
2014-05 0 $0 183,127 $13,142,589 183,127 $4,592,253
2014-04 0 $0 10,384 $710,888 10,384 $174,451
2014-03 5,000 $365,000 80,637 $5,842,013 80,637 $2,357,124

Table 2. Detailed insider stock purchases, sales, and option exercises of Endo International Plc insiders (ENDP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-15 Coleman Blaise (EVP, Chief Financial Officer) Buy 6,500 7.89 51,285
2017-08-15 Maletta Matthew Joseph (EVP, Chief Legal Officer) Buy 3,000 8.02 24,060
2017-08-14 Campanelli Paul (President, CEO) Buy 6,500 7.71 50,115
2017-08-10 Coughlin Terrance J (EVP, Chief Operating Officer) Buy 20,000 7.70 154,000
2017-03-16 Campanelli Paul (President, CEO) Buy 2,300 10.72 24,656
2017-03-09 Hutson Nancy J (Director) Sale 5,325 10.82 57,616
2016-11-15 Kimmel Roger H (Director) Sale 14,000 17.79 249,060
2016-05-11 Higgins Arthur J (Director) Buy 5,000 13.80 69,000
2016-05-10 Campanelli Paul (Group President, Generics) Buy 13,000 15.53 201,890
2016-05-10 Higgins Arthur J (Director) Buy 11,000 15.42 169,620
2016-05-10 Kimmel Roger H (Director) Buy 7,000 15.57 108,990
2016-03-21 De Silva Rajiv (President & CEO) Option Ex 143,818 .00 0
2016-03-17 Spengler William (Director) Buy 1,000 29.20 29,200
2016-03-16 Spengler William (Director) Buy 1,000 35.24 35,240
2016-03-14 Kimmel Roger H (Director) Buy 1,125 41.94 47,182
2016-03-11 Kimmel Roger H (Director) Option Ex 6,764 41.67 281,855
2016-03-07 Maletta Matthew Joseph (Exec. V.P.,Chief Legal Officer) Buy 500 44.48 22,240
2016-03-07 De Silva Rajiv (President & CEO) Buy 2,250 44.50 100,125
2016-03-02 Lortie Brian (President Branded Pharma) Option Ex 12,977 .00 0
2016-03-01 Smith Jill D. (Director) Sale 3,413 42.19 143,994
2016-03-01 Hutson Nancy J (Director) Sale 3,413 42.19 143,994
2016-03-01 Spengler William (Director) Sale 3,413 42.19 143,994
2016-03-01 Hyatt Michael (Director) Sale 3,413 42.19 143,994
2015-11-16 Kimmel Roger H (Director) Buy 841 57.00 47,937
2015-11-12 Cooke Shane (Director) Buy 4,000 57.13 228,520
2015-11-11 Maletta Matthew Joseph (Exec. V.P.,Chief Legal Officer) Buy 500 56.19 28,095
2015-11-11 Lortie Brian (President Branded Pharma) Buy 700 56.47 39,529
2015-11-11 Hall Susan (EVP, CSO, Global Head of R&D) Buy 1,000 55.35 55,350
2015-11-11 Upadhyay Suketu (EVP, Chief Financial Officer) Buy 4,450 55.99 249,177
2015-11-11 De Silva Rajiv (President & CEO) Buy 9,006 55.52 500,013
2015-11-11 Campanelli Paul (President, Par Pharmaceutical) Buy 2,100 56.00 117,600
2015-11-11 Hyatt Michael (Director) Sale 8,000 55.48 443,840
2015-11-11 Hyatt Michael (Director) Option Ex 10,000 31.43 314,300
2015-11-11 Kimmel Roger H (Director) Option Ex 10,384 16.80 174,451
2015-11-05 Kimmel Roger H (Director) Option Ex 10,000 53.91 539,100
2015-06-16 Higgins Arthur J (Director) Buy 2,500 81.10 202,750
2015-04-08 Manogue Caroline B (Exec. V.P.,Chief Legal Officer) Sale 105,059 91.90 9,654,922
2015-04-08 Manogue Caroline B (Exec. V.P.,Chief Legal Officer) Option Ex 105,059 29.76 3,126,871
2015-04-07 Manogue Caroline B (Exec. V.P.,Chief Legal Officer) Sale 503 91.90 46,225
2015-04-07 Manogue Caroline B (Exec. V.P.,Chief Legal Officer) Option Ex 503 20.61 10,366
2015-03-09 Farhat Camille (President, AMS, Inc.) Sale 40,438 87.02 3,518,914
2015-03-09 Farhat Camille (President, AMS, Inc.) Option Ex 40,438 31.54 1,275,212
2015-03-05 Manogue Caroline B (Exec. V.P.,Chief Legal Officer) Sale 42,033 87.78 3,689,656
2015-03-05 Manogue Caroline B (Exec. V.P.,Chief Legal Officer) Option Ex 42,033 19.93 837,717
2015-03-04 Lortie Brian (President Branded Pharma) Sale 5,800 85.35 495,029
2014-11-14 Upadhyay Suketu (EVP, Chief Financial Officer) Buy 3,700 66.94 247,678
2014-10-14 Kimmel Roger H (Director) Option Ex 4,567 29.84 136,279
2014-08-19 Hyatt Michael (Director) Option Ex 10,000 22.06 220,600
2014-08-11 Kimmel Roger H (Director) Option Ex 10,000 22.06 220,600
2014-08-05 Higgins Arthur J (Director) Buy 3,500 65.65 229,775
2014-06-09 Delucca John (Director) Sale 6,764 68.83 465,566
2014-06-09 Delucca John (Director) Option Ex 6,764 24.63 166,597
2014-05-29 Manogue Caroline B (Exec. V.P., CLO & Secy) Sale 175,033 72.02 12,605,876
2014-05-29 Manogue Caroline B (Exec. V.P., CLO & Secy) Option Ex 175,033 25.14 4,399,454
2014-05-01 Delucca John (Director) Sale 8,094 66.31 536,713
2014-05-01 Delucca John (Director) Option Ex 8,094 23.82 192,799
2014-04-01 Delucca John (Director) Sale 10,384 68.46 710,888
2014-04-01 Delucca John (Director) Option Ex 10,384 16.80 174,451
2014-03-10 Hutson Nancy J (Director) Sale 5,000 72.12 360,600
2014-03-10 Hutson Nancy J (Director) Option Ex 5,000 17.27 86,350
2014-03-10 Gergel Ivan P. (EVP, R&D and CSO) Sale 75,637 72.47 5,481,413
2014-03-10 Gergel Ivan P. (EVP, R&D and CSO) Option Ex 75,637 30.02 2,270,774
2014-03-10 Higgins Arthur J (Director) Buy 5,000 73.00 365,000

Insider trading activities including stock purchases, stock sales, and option exercises of ENDP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Endo International Plc (symbol ENDP, CIK number 1593034) see the Securities and Exchange Commission (SEC) website.